Right Targets. Right Cells. Right Place.

Unlocking the power of T cells against oncogenic driver mutations

Learn More

Right Targets. Right Cells. Right Place.

Unlocking the power of T cells against oncogenic driver mutations

Learn More

Right Targets. Right Cells. Right Place.

Unlocking the power of T cells against oncogenic driver mutations

Learn More

Right Targets. Right Cells. Right Place.

Unlocking the power of T cells against oncogenic driver mutations

Learn More

Right Targets. Right Cells. Right Place.

Unlocking the power of T cells against oncogenic driver mutations

Learn More

Latest News

01.07.2024

Affini-T Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Press Releases

11.13.2023

Affini-T Therapeutics Appoints Healthcare Capital Markets Veteran Kathy Bergsteinsson, MBA, as Chief Financial Officer

Press Releases

10.31.2023

Affini-T Therapeutics to Present Preclinical Gene Editing Data from its Program Targeting KRAS G12D at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting

Press Releases

Read More

Team

Technology

Pipeline